IMO it's an early sign that significant changes could certainly be afoot behind the scenes on this one, and who may be joining the growth driving mission ahead, both potential companies wise, vendors wise of course, higher tiered funders wise, and investors wise.
I honestly don't know what all's afoot! I just know the Yuengling's brand basically sells itself, and there's a lot of reasons why other investors and companies would have for wanting to hitch their wagons to such a well known brand as Yuengling's right!
So we'll soon see how it all unfolds, but rest assured there's a good reason this CEO has barely tapped the Reg A or diluted this year to date. And that reason imo has everything to do with the incredible vote of confidence Mid Penn Bank themselves provided him with in the 1st place, and absolutely nothing to do with this CEO's supposed past track record on the OTC.
But of course in this age of social media, everyone supposedly knows more than Mid Penn Bank, both Yuengling's executives and the companies and investors behind the scenes clearly negotiating with ARSN's CEO about the next cycle of growth ARSN is positioning itself to begin to move into glta
News 
Market Data 
Discover 
